ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 151

Residual Synovitis in Ultrasound (US) Is Associated with an Evolution Towards Rheumatoid Arthritis  (RA) in Patients with Inflammatory Polyarthralgia without ANTI-Citrulinated Antibodies (ACPA)

Pascal Zufferey1,2,3, Claudia Rebell Jr.4, Alexandre Dumusc5, Mauro lucini4, Juerg Hains6, Alexander K. So Sr.7 and Charles Benaim8, 1Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland, 2Pierer Decler, Chuv, Lausanne, Switzerland, 3Rhu /Dal .Chuv, Rheumatology, Lausanne, Switzerland, 4DAL, RHU/CHUV, lausanne, Switzerland, 5RHU/CHUV, lausanne, Switzerland, 6DAL, RHU/CHUV, Lausanne, Syria, 7Service De Rhumatologie, CHUV, Lausanne, Switzerland, 8DAL, MPR, Lausanne, Switzerland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: ACPA, Diagnostic criteria, polyarthritis, synovitis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

In ACPA positive patients, subclinical synovitis as observed
by US has been demonstrated in pre RA patients and seems to be predictive for
future development of RA [1]. No such study has yet been conducted in ACPA
negative patients.

The primary aim of the study was to assess the value of the
US as a screening tool to detect early joint involvement in ACPA- patients
complaining of polyarthralgia and to analyse whether such subclinical synovitis
is predictive for the future development of  an inflammatory  disease, in
particular RA. The secondary aims were to look for additional clinical and
biological predictors of RA development in ACPA- patients

Methods:

This is a retrospective observational study of 101
consecutive ACPA- patients with poly-arthralgia who did not meet the ACR /
EULAR 2010 criteria for RA or classification criteria for another inflammatory
rheumatology disease before the US examination. These patients were all seen in
investigation in our ambulatory unit between 2009 and 2013. To detect
significant US synovitis, we applied the criteria of the SONAR score validated
among RA patients and controls [2](total B mode score >8, > 2 synovitis:
grade 2). For the follow-up, the same diagnostic criteria as baseline were
used.

Results:

At baseline (30%) had significant synovitis according to the
SONAR criteria. The mean (SD) follow-up time was 18 (7) months in both groups.
17 patients developed a clear inflammatory arthritis (11 RA, 6 another
inflammatory arthritis disease). Significant US synovitis at baseline was
significantly associated with evolution to RA: 7/28 versus 4/69 (<0.005),
sensitivity: 64% specificity: 76%, LR: 2.7. Elevated CRP and clinical synovitis
appeared to be additional predictors of such an evolution. Figure depicts the
arthritis free curves (a: before RA, b: before all inflammatory arthritis)
according to the presence or not of US synovitis at baseline

Conclusion:

Our study suggests that US can be used as a predictor for
the evolution to RA in patients presenting inflammatory polyarthralgia without
ACPA.

 

 References:  1: Ann Rheum Dis 2010; 69:417–419, 2: Joint
Bone Spine. 2014 Oct;81(5):426-32


Disclosure: P. Zufferey, None; C. Rebell Jr., None; A. Dumusc, None; M. lucini, None; J. Hains, None; A. K. So Sr., None; C. Benaim, None.

To cite this abstract in AMA style:

Zufferey P, Rebell C Jr., Dumusc A, lucini M, Hains J, So AK Sr., Benaim C. Residual Synovitis in Ultrasound (US) Is Associated with an Evolution Towards Rheumatoid Arthritis  (RA) in Patients with Inflammatory Polyarthralgia without ANTI-Citrulinated Antibodies (ACPA) [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/residual-synovitis-in-ultrasound-us-is-associated-with-an-evolution-towards-rheumatoid-arthritis-ra-in-patients-with-inflammatory-polyarthralgia-without-anti-citrulinated-antibodies-acpa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/residual-synovitis-in-ultrasound-us-is-associated-with-an-evolution-towards-rheumatoid-arthritis-ra-in-patients-with-inflammatory-polyarthralgia-without-anti-citrulinated-antibodies-acpa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology